Valneva SE (VALN) Cash from Operations Growth (1y) (2022 - 2026)
Valneva SE (VALN) Cash from Operations Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Ops. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
85.14% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
74.39% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Valneva SE |
167.33 Mn |
44.10 Mn |
5.08 Mn |
95.51% |
| Date | Value |
|---|
| Mar 31, 2026 |
95.51% |
| Dec 31, 2025 |
-433.22% |
| Sep 30, 2025 |
-69.23% |
| Jun 30, 2025 |
92.49% |
| Mar 31, 2025 |
73.53% |
| Dec 31, 2024 |
112.24% |
| Sep 30, 2024 |
-100.02% |
| Jun 30, 2024 |
99.94% |
| Mar 31, 2024 |
-17.76% |
| Dec 31, 2023 |
-20.17% |
| Sep 30, 2023 |
79,290.74% |
| Jun 30, 2023 |
-91,891.49% |
| Mar 31, 2023 |
13.36% |
| Dec 31, 2022 |
-220.29% |
| Sep 30, 2022 |
-59.25% |
| Jun 30, 2022 |
-275.24% |
| Mar 31, 2022 |
-152.53% |
